S2 Ep6: S2 #6 The Public Good: Maximising Outcomes
Impossibile aggiungere al carrello
Puoi avere soltanto 50 titoli nel carrello per il checkout.
Riprova più tardi
Riprova più tardi
Rimozione dalla Lista desideri non riuscita.
Riprova più tardi
Non è stato possibile aggiungere il titolo alla Libreria
Per favore riprova
Non è stato possibile seguire il Podcast
Per favore riprova
Esecuzione del comando Non seguire più non riuscita
S2 Ep6: S2 #6 The Public Good: Maximising Outcomes
-
Letto da:
-
Di:
We have all felt the impact of the pandemic in 2020 and 2021 - but we have not felt it equally. In this episode, the last of this series, host Bruno Giussani dives into the ecosystems around scientific innovation, looking at the way different forms of collaboration, legal frameworks, and the respective roles of public institutions, private companies and philanthropy in enabling (or not) technological advances. Joining Bruno are the director of the Wellcome Trust, Jeremy Farrar, reflecting on the role of philanthropic organisations as well as the necessity of long-term investment in science, discovery and education; Soumya Swaminathan, chief scientist at the WHO, talking about the role the WHO plays on the international stage and the struggles for equity in treatment - and the WHO’s first mRNA technology transfer hub in Africa; Els Torreele, biomedical scientist and researcher in equitable public health policy, diving deep into the effects of patent-driven and commercially-funded medical research; and Ben Perry, medicinal chemist involved in drug discovery, commenting on the complexities of molecule control.
Guests: Els Torreele, Ben Perry, Jeremy Farrar, Soumya Swaminathan
Host: Bruno Giussani
Production
CERN, Geneva: Claudia Marcelloni, Lila Mabiala, Sofia Hurst
Whistledown Productions, London: Will Yates and Sandra Kanthal
Copyright: CERN, 2022
adbl_web_anon_alc_button_suppression_t1
Ancora nessuna recensione